Secondary analysis of the ACCURE trial (65 Dutch patients with ulcerative colitis in remission): active appendiceal inflammation was found in 55.4%; extensive epithelial neutrophil involvement showed a trend to more relapse (44.4% vs 18.0%; p=0.05).
Secondary analysisn = 65
Visser et al. Histopathological Findings of Appendix Specimens in Quiescent Ulcerative Colitis: Correlations With Clinical Outcomes in the ACCURE Trial